Christian Voigtlander - May 27, 2025 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Signature
By: Paula Darbyshire, Attorney-in-Fact For: Christian Voigtlander
Stock symbol
ICUI
Transactions as of
May 27, 2025
Transactions value $
-$212,106
Form type
4
Date filed
5/28/2025, 12:00 PM
Previous filing
May 23, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Voigtlander Christian B. Chief Operating Officer 951 CALLE AMANECER, SAN CLEMENTE By: Paula Darbyshire, Attorney-in-Fact For: Christian Voigtlander 2025-05-28 0001727477

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICUI Common Stock Options Exercise $538K +5.56K +113.3% $96.83 10.5K May 27, 2025 Direct
transaction ICUI Common Stock Sale -$648K -4.95K -47.28% $131.00 5.51K May 27, 2025 Direct F1
transaction ICUI Common Stock Options Exercise $538K +5.56K +100.85% $96.83 11.1K May 28, 2025 Direct
transaction ICUI Common Stock Sale -$641K -4.99K -45.02% $128.50 6.09K May 28, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICUI Non-Qualified Stock Option (right to buy) Options Exercise $0 -5.56K -49.98% $0.00 5.56K May 27, 2025 Common Stock 5.56K $96.83 Direct
transaction ICUI Non-Qualified Stock Option (right to buy) Options Exercise $0 -5.56K -100% $0.00 0 May 28, 2025 Common Stock 5.56K $96.83 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All shares sold were sold at the exact price disclosed.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.50 to $128.54 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.